Compositions of human endothelial cell growth factor
US5827826A · kind A · utility
4Cited by
18References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 4, 1996 |
| Grant date | Oct 27, 1998 |
| Priority date | — |
| Expiry date | Nov 4, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compositions comprising endothelial cell growth factor, an acceptable carrier and, optionally, an extracellular matrix protein, a glycosaminoglycan or serum albumin. The compositions are useful for wound repair.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.